RSS   Newsletter   Contact   Advertise with us
Post Online Media

Casebia Therapeutics appoints James W. Burns as CEO

Casebia TherapeuticsCasebia Therapeutics, the joint venture founded by Bayer and CRISPR Therapeutics, announced that James W. Burns has been appointed president and chief executive officer.

Dr. Burns brings to Casebia Therapeutics nearly 30 years of R&D experience in the biopharmaceutical industry and a proven track record of leading R&D organizations that have successfully delivered therapeutics to patients.

Prior to joining Casebia, Dr. Burns spent the bulk of his career at Sanofi-Genzyme. First joining Genzyme in 1986, he had several leadership roles with increasing responsibility.

Most recently as the Head of Sanofi’s North American R&D Hub, he was responsible for coordinating R&D operations across key therapeutic areas.

Dr. Burns is a former board member of MassBio, a member of the U.S. National Academy of Engineering and is Chair of the External Advisory Committee for the Biomedical Engineering Department at Boston University.

He served from 1996-1999 as the Industry Representative for the Food and Drug Administration General and Plastic Surgery Panel.

Dr. Burns earned a Bachelor of Science degree in Biology from Purdue University, and Master of Science and Doctorate degrees in Bioengineering from the University of Illinois-Chicago, where his thesis work focused on drug delivery.

Following his graduate studies, Dr. Burns was a post-doctoral researcher at the University of Florida.


 LATEST MOVES FROM Massachusetts 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy